Cargando…
Testing the mutant selection window hypothesis with meropenem: In vitro model study with OXA-48-producing Klebsiella pneumoniae
OXA-48 carbapenemases are frequently expressed by Klebsiella pneumoniae clinical isolates; they decrease the effectiveness of carbapenem therapy, particularly with meropenem. Among these isolates, meropenem-susceptible carbapenemase-producers may show decreased meropenem effectiveness. However, the...
Autores principales: | Alieva, Kamilla N., Golikova, Maria V., Dovzhenko, Svetlana A., Kobrin, Mikhail B., Strukova, Elena N., Ageevets, Vladimir A., Avdeeva, Alisa A., Sulian, Ofeliia S., Sidorenko, Sergey V., Zinner, Stephen H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403107/ https://www.ncbi.nlm.nih.gov/pubmed/37540701 http://dx.doi.org/10.1371/journal.pone.0288660 |
Ejemplares similares
-
Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing Klebsiella pneumoniae
por: Golikova, Maria V., et al.
Publicado: (2023) -
Klebsiella pneumoniae Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio
por: Golikova, Maria V., et al.
Publicado: (2022) -
Fluorescence Microscopy: Determination of Meropenem Activity against Klebsiella pneumoniae
por: Alieva, Kamilla N., et al.
Publicado: (2023) -
Emergence of Hybrid Resistance and Virulence Plasmids Harboring New Delhi Metallo-β-Lactamase in Klebsiella pneumoniae in Russia
por: Starkova, Polina, et al.
Publicado: (2021) -
2746. Assessment of in vitro synergy between Piperacillin-Tazobactam-Meropenem and Imipenem-Meropenem against OXA-48 Producing Klebsiella pneumoniae Using Time-Kill Assays
por: Demir, Mervenur, et al.
Publicado: (2023)